MedPath

Analysis of NK cell function in patients with multiple myeloma

Not Applicable
Recruiting
Conditions
Multiple myeloma
Registration Number
JPRN-UMIN000022764
Lead Sponsor
Division of Hematology National Center for Global Health and Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1)Who does not agree with the participation into the study. 2)Who can not understant the explanation about this study. 3)Who should be excluded judged by principal investigator.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To analyze the quantitive and qualitative status in patients with multiple myeloma. 1)The number of NK cells 2)Surface proteins 3)Cytotoxic activities 4)Response to cytokines in NK cells
Secondary Outcome Measures
NameTimeMethod
To evaluate the effect of monoclonal antibodies on NK cells. 1)Proliferation effects 2)Survival effects 3)Cytotoxic activities To evaluate the effect of NK cells on myeloma cells. 4)Cytotoxic activities of NK cells against myeloma cells 5)Effects of chemotherapy and stem cell transplantation on NK cells
© Copyright 2025. All Rights Reserved by MedPath